New study aims to improve anal cancer screening for those at highest risk
NCT ID NCT06628570
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study looks at different screening methods to find anal precancer in people at high risk, such as those with weakened immune systems or a history of certain genital cancers. Researchers will compare tests like high-resolution anoscopy, HPV testing, and cell samples to see which works best. The goal is to improve early detection and understand factors linked to the disease.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better, more accurate screening tests for anal precancer in high-risk people, helping catch it early.
- What could go wrong
- This is an early-stage study focused on comparing screening methods, not testing a treatment. Results may not change current practice immediately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Grady Memorial Hospital
RECRUITINGAtlanta, Georgia, 30303, United States
-
The Ponce Center
RECRUITINGAtlanta, Georgia, 30308, United States
-
University of Miami Miller School of Medicine-Sylvester Cancer Center
RECRUITINGMiami, Florida, 33136, United States
-
University of Miami School of Medicine at Jackson Memorial Hospital (JMH)
RECRUITINGMiami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a simple text message transform cancer care?
- Can modern Radiotherapy's late effects be predicted?
- One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva